Ethical questions surround Parkinson's stem cell experimental treatment

Reprogramming a patient's own skin cells to replace cells in the brain that are progressively lost during Parkinson's disease has been shown to be technically feasible, reports a team of investigators from McLean Hospital and Massachusetts General Hospita